NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Using Technology to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing Options
Using Technology to Match Young Black Men and Transwomen Who Have Sex With Men or Transwomen to HIV Testing Options

NCT02834572

TerminatedNA

Sponsor: New York Blood Center

Conditions: HIV Testing

Interventions: All About Me, Control

Countries: United States

Young Black men who have sex with men (MSM) and transwomen in the US are affected by HIV at severely disproportionate rates. A key component of HIV prevention for communities at risk is diagnosing HIV infections through regular HIV testing. A significant proportion of young Black MSM and transwomen have not tested in the prior year. This research study seeks to address low HIV testing rates among young Black MSM and transwomen by testing a brief Internet-based HIV testing intervention optimized for mobile devices. The intervention takes advantage of the variety of HIV testing options now available, including the HIV self testing, couples-based HIV counseling and testing and traditional clinic-based testing and will provide men and transwomen with a tailored recommendation of their optimal HIV testing approach. The investigators are conducting a pilot randomized study among young Black MSM and transwomen followed for 6 months to estimate the intervention's potential efficacy in increasing HIV testing.

Eligibility overview

Sex: ALL

Age: 16 Years to 29 Years

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria
Inclusion Criteria:

* male at birth;
* self-identify as Black, African American, Caribbean Black, African Black or multiethnic Black;
* able to read and respond in English;
* between 16-29 years of age;
* known to be HIV-infected;
* insertive or receptive anal intercourse with a man or transwoman in the last 12 months;
* reside in the New York City metropolitan area

Exclusion Criteria:

* enrolled in any other HIV research study involving HIV testing
* participant in an HIV vaccine trial
* currently taking pre-exposure prophylaxis
Locations (1)
  • New York, New York, United States